瓦克赛特生物 PCVX
$63.89 +$1.97 (+3.18%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $64.05 +0.25%
开盘$61.92
昨收$61.92
当日区间$61.14 – $65.30
成交量1.84M
市值$10.11B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例107.5%-9.54 个百分点，较上季度
持仓机构数415+7 ，较上季度
内部人近期交易19次买入 / 30次卖出净卖出
空头持仓比例9.29% 占流通股回补天数 2.9 · 截至 15 Oct 2026
卖空成交量占比21.1%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$14.06M（10个净流入日，10个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有48.2%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从10.02%降至9.29%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +2,862,315 | 12.2% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +2,094,003 | 9.7% |
| Strategic Advisers LLC | Mutual Fund | 2026/Q3 | +1,497,731 | 1.1% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +1,386,968 | 4.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,096,313 | 7.7% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +911,179 | 3.4% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +818,982 | 0.8% |
| Bellevue Asset Management AG | Mutual Fund | 2026/Q3 | +781,238 | 1.3% |
| ClearBridge Investments, LLC | Mutual Fund | 2026/Q3 | +623,622 | 0.5% |
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +530,000 | 0.6% |
| First Turn Management, LLC | Hedge Fund | 2026/Q3 | +443,836 | 0.3% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +426,330 | 0.5% |
| Columbia Management Investment Advisers, LLC | Mutual Fund | 2026/Q3 | +329,519 | 0.3% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +314,006 | 4.2% |
| J.P. Morgan Asset Management, Inc. | Mutual Fund | 2026/Q3 | +280,370 | 0.7% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 4 Oct 2026 | James Wassil | Chief Operating Officer | Intent to Sell (Form 144) | -18,000 | $86.74 | – |
| 4 Oct 2026 | James Wassil | Executive VP, Chief Scientific Officer & COO | Derivative Exercise and Sale | -18,000 | $86.74 | 145,435 |
| 4 Oct 2026 | Elvia Cowan | Senior VP of Finance & Principal Accounting Officer | Intent to Sell (Form 144) | -19,000 | $86.74 | – |
| 4 Oct 2026 | Elvia Cowan | Senior VP of Finance & Chief Accounting Officer | Derivative Exercise and Sale | -19,000 | $86.74 | 14,054 |
| 30 Sep 2026 | James Wassil | Executive VP, Chief Scientific Officer & COO | Derivative Exercise and Sale | -2,250 | $57.09 | 145,435 |
| 8 Sep 2026 | James Wassil | Executive VP, Chief Scientific Officer & COO | Intent to Sell (Form 144) | -1,334 | $59.99 | – |
| 8 Sep 2026 | James Wassil | Executive VP, Chief Scientific Officer & COO | Automatic Disposition | -2,715 | $61.16 | 145,435 |
| 7 Sep 2026 | Andrew Guggenhime | President | Sale to Issuer | -7,155 | $60.36 | 107,138 |
| 7 Sep 2026 | Grant Pickering | Chief Executive Officer | Sale to Issuer | -17,056 | $60.36 | 577,281 |
| 7 Sep 2026 | James Wassil | Executive VP, Chief Scientific Officer & COO | Sale to Issuer | -5,459 | $60.36 | 145,435 |
| 7 Sep 2026 | Elvia Cowan | Senior VP of Finance & Chief Accounting Officer | Sale to Issuer | -1,327 | $60.36 | 14,054 |
| 7 Sep 2026 | Harpreet Dhaliwal | Sale to Issuer | -7,651 | $60.36 | 19,278 | |
| 3 Sep 2026 | James Wassil | Executive VP, Chief Scientific Officer & COO | Intent to Sell (Form 144) | -1,381 | $59.73 | – |
| 3 Sep 2026 | Luis Jodar | Chief Medical Officer | Other Acquisition | +52,632 | – | 52,632 |
| 3 Sep 2026 | Luis Jodar | Chief Medical Officer | Other Derivative Acquisition | +88,254 | $61.16 | 88,254 |
| 1 Sep 2026 | Andrew Guggenhime | President | Sale to Issuer | -2,705 | $61.58 | 100,231 |
| 1 Sep 2026 | Grant Pickering | Chief Executive Officer | Sale to Issuer | -6,289 | $61.58 | 560,817 |
| 1 Sep 2026 | James Wassil | Executive VP, Chief Scientific Officer & COO | Sale to Issuer | -2,705 | $61.58 | 153,609 |
| 1 Sep 2026 | Elvia Cowan | Senior VP of Finance & Chief Accounting Officer | Sale to Issuer | -569 | $61.58 | 11,687 |
| 1 Sep 2026 | Harpreet Dhaliwal | Sale to Issuer | -1,020 | $61.58 | 11,911 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 14,623,649 | 9.3% | 2.9 |
| 30 Sep 2026 | 17,290,712 | 11.6% | 11.4 |
| 15 Sep 2026 | 16,132,520 | 10.8% | 13.0 |
| 31 Aug 2026 | 15,016,514 | 10.1% | 15.9 |
| 14 Aug 2026 | 14,796,265 | 9.9% | 15.9 |
| 31 Jul 2026 | 14,464,951 | 10.0% | 14.8 |
暂无评论——快来第一个聊聊 PCVX。
登录后参与讨论。